Patents by Inventor Melitta Bilban

Melitta Bilban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Injectable fibrin composition for bone augmentation
    Patent number: 9724449
    Abstract: The present invention relates to a biodegradable injectable composition for bone augmentation comprising fibrin, a contrast agent and calcium salt-containing particles, as well as a method for bone augmentation in a patient suffering from a bone disorder comprising injecting said composition into a non-mineralized or hollow portion of said bone.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: August 8, 2017
    Assignees: Baxter International Inc., Baxter Healthcare, S.A.
    Inventors: John J. Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban
  • Injectable fibrin composition for bone augmentation
    Patent number: 9421302
    Abstract: The present invention relates to a biodegradable injectable composition for bone augmentation comprising fibrin, a contrast agent and calcium salt-containing particles, as well as a method for bone augmentation in a patient suffering from a bone disorder comprising injecting said composition into a non-mineralized or hollow portion of said bone.
    Type: Grant
    Filed: April 17, 2007
    Date of Patent: August 23, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: John J. Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban
  • Injectable void filler for soft tissue augmentation
    Patent number: 9278160
    Abstract: The present invention teaches a micro-porous injectable, soft elastic, fully resorbable fibrin-based composition for use as a soft tissue lumen and void filler. The composition of the present application exhibits physical characteristics, such as mechanical properties, typically seen in elastomers and mechanical stability, which is superior to fibrin alone. A variety of properties of the composition of the present invention can be effectively fine-tuned and altered by adjusting type and content of the particles as well as of the plasticizer contained in the void filler composition.
    Type: Grant
    Filed: January 10, 2013
    Date of Patent: March 8, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: John J. Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban
  • Injectable bone void filler
    Patent number: 9248215
    Abstract: The present invention relates to a biodegradable fibrin based composition for injection into osseous defects or voids, which can be the result of osteoporosis, surgery, bone cysts, tumor removal or traumatic bone injury.
    Type: Grant
    Filed: April 17, 2007
    Date of Patent: February 2, 2016
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: John J. Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban
  • INJECTABLE FIBRIN COMPOSITION FOR BONE AUGMENTATION
    Publication number: 20150352253
    Abstract: The present invention relates to a biodegradable injectable composition for bone augmentation comprising fibrin, a contrast agent and calcium salt-containing particles, as well as a method for bone augmentation in a patient suffering from a bone disorder comprising injecting said composition into a non-mineralized or hollow portion of said bone.
    Type: Application
    Filed: August 17, 2015
    Publication date: December 10, 2015
    Inventors: John J. Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban
  • Injectable void filler for soft tissue augmentation
    Patent number: 8377420
    Abstract: The present invention teaches a micro-porous injectable, soft elastic, fully resorbable fibrin-based composition for use as a soft tissue lumen and void filler. The composition of the present application exhibits physical characteristics, such as mechanical properties, typically seen in elastomers and mechanical stability, which is superior to fibrin alone. A variety of properties of the composition of the present invention can be effectively fine-tuned and altered by adjusting type and content of the particles as well as of the plasticizer contained in the void filler composition.
    Type: Grant
    Filed: January 11, 2011
    Date of Patent: February 19, 2013
    Assignees: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: John J. Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban
  • INJECTABLE VOID FILLER FOR SOFT TISSUE AUGMENTATION
    Publication number: 20110117027
    Abstract: The present invention teaches a micro-porous injectable, soft elastic, fully resorbable fibrin-based composition for use as a soft tissue lumen and void filler. The composition of the present application exhibits physical characteristics, such as mechanical properties, typically seen in elastomers and mechanical stability, which is superior to fibrin alone. A variety of properties of the composition of the present invention can be effectively fine-tuned and altered by adjusting type and content of the particles as well as of the plasticizer contained in the void filler composition.
    Type: Application
    Filed: January 11, 2011
    Publication date: May 19, 2011
    Applicants: Baxter Healthcare S.A., Baxter International Inc.
    Inventors: John J. Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban
  • INJECTABLE VOID FILLER FOR SOFT TISSUE AUGMENTATION
    Publication number: 20080241072
    Abstract: The present invention teaches a micro-porous injectable, soft elastic, fully resorbable fibrin-based composition for use as a soft tissue lumen and void filler. The composition of the present application exhibits physical characteristics, such as mechanical properties, typically seen in elastomers and mechanical stability, which is superior to fibrin alone. A variety of properties of the composition of the present invention can be effectively fine-tuned and altered by adjusting type and content of the particles as well as of the plasticizer contained in the void filler composition.
    Type: Application
    Filed: March 25, 2008
    Publication date: October 2, 2008
    Applicants: Baxter International Inc., Baxter Healthcare S.A.
    Inventors: John J. Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban
  • INJECTABLE FIBRIN COMPOSITION FOR BONE AUGMENTATION
    Publication number: 20070275028
    Abstract: The present invention relates to a biodegradable injectable composition for bone augmentation comprising fibrin, a contrast agent and calcium salt-containing particles, as well as a method for bone augmentation in a patient suffering from a bone disorder comprising injecting said composition into a non-mineralized or hollow portion of said bone.
    Type: Application
    Filed: April 17, 2007
    Publication date: November 29, 2007
    Applicants: Baxter International Inc., Baxter Healthcare, S.A.
    Inventors: John Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban
  • INJECTABLE BONE VOID FILLER
    Publication number: 20070276505
    Abstract: The present invention relates to a biodegradable fibrin based composition for injection into osseous defects or voids, which can be the result of osteoporosis, surgery, bone cysts, tumor removal or traumatic bone injury.
    Type: Application
    Filed: April 17, 2007
    Publication date: November 29, 2007
    Applicants: Baxter International Inc., Baxter Healthcare, S.A.
    Inventors: John Barry, Andreas Goessl, Heinz Gulle, Monika Mangold, Melitta Bilban